Rhumbline Advisers CASI PHARMACEUTICALS INC COM Transaction History

Rhumbline Advisers

  • $104 Billion
  • Q1 2025

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
N/A
-71,591 Closed
0 $0
Q1 2021

May 06, 2021
SELL
N/A
-1,695 Reduced 2.31%
71,591 $172,000
Q4 2020

Feb 10, 2021
BUY
N/A
7,533 Added 11.46%
73,286 $216,000
Q3 2020

Nov 12, 2020
SELL
N/A
-8,277 Reduced 11.18%
65,753 $101,000
Q2 2020

Aug 13, 2020
BUY
N/A
8,475 Added 12.93%
74,030 $185,000
Q4 2019

Feb 05, 2020
BUY
N/A
168 Added 0.26%
65,555 $203,000
Q3 2019

Oct 23, 2019
BUY
N/A
262 Added 0.4%
65,387 $218,000
Q2 2019

Aug 14, 2019
BUY
N/A
1,372 Added 2.15%
65,125 $208,000
Q1 2019

May 01, 2019
SELL
N/A
-642 Reduced 1.0%
63,753 $183,000
Q4 2018

Jan 31, 2019
BUY
N/A
21,563 Added 50.34%
64,395 $259,000
Q3 2018

Nov 07, 2018
SELL
N/A
-2,620 Reduced 5.76%
42,832 $200,000
Q2 2018

Aug 06, 2018
BUY
N/A
45,452 New
45,452 $374,000
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email